Resonance Health Ltd (RHT) - Net Assets
Based on the latest financial reports, Resonance Health Ltd (RHT) has net assets worth AU$10.94 Million AUD (≈ $7.74 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$17.96 Million ≈ $12.71 Million USD) and total liabilities (AU$7.02 Million ≈ $4.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Resonance Health Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$10.94 Million |
| % of Total Assets | 60.9% |
| Annual Growth Rate | 1.81% |
| 5-Year Change | -20.6% |
| 10-Year Change | 132.8% |
| Growth Volatility | 118.24 |
Resonance Health Ltd - Net Assets Trend (1989–2025)
This chart illustrates how Resonance Health Ltd's net assets have evolved over time, based on quarterly financial data. Also explore RHT total assets for the complete picture of this company's asset base.
Annual Net Assets for Resonance Health Ltd (1989–2025)
The table below shows the annual net assets of Resonance Health Ltd from 1989 to 2025. For live valuation and market cap data, see market value of Resonance Health Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$9.39 Million ≈ $6.64 Million |
-14.10% |
| 2024-06-30 | AU$10.93 Million ≈ $7.73 Million |
+10.03% |
| 2023-06-30 | AU$9.94 Million ≈ $7.03 Million |
-7.07% |
| 2022-06-30 | AU$10.69 Million ≈ $7.56 Million |
-9.61% |
| 2021-06-30 | AU$11.83 Million ≈ $8.37 Million |
+19.40% |
| 2020-06-30 | AU$9.91 Million ≈ $7.01 Million |
+68.08% |
| 2019-06-30 | AU$5.89 Million ≈ $4.17 Million |
+42.56% |
| 2018-06-30 | AU$4.13 Million ≈ $2.93 Million |
+10.70% |
| 2017-06-30 | AU$3.73 Million ≈ $2.64 Million |
-7.42% |
| 2016-06-30 | AU$4.03 Million ≈ $2.85 Million |
-8.43% |
| 2015-06-30 | AU$4.41 Million ≈ $3.12 Million |
+31.95% |
| 2014-06-30 | AU$3.34 Million ≈ $2.36 Million |
+48.98% |
| 2013-06-30 | AU$2.24 Million ≈ $1.59 Million |
-12.67% |
| 2012-06-30 | AU$2.57 Million ≈ $1.82 Million |
-11.38% |
| 2011-06-30 | AU$2.90 Million ≈ $2.05 Million |
-9.75% |
| 2010-06-30 | AU$3.21 Million ≈ $2.27 Million |
-2.84% |
| 2009-06-30 | AU$3.30 Million ≈ $2.34 Million |
+23.44% |
| 2008-06-30 | AU$2.68 Million ≈ $1.89 Million |
-1.69% |
| 2007-06-30 | AU$2.72 Million ≈ $1.93 Million |
+433.19% |
| 2006-06-30 | AU$510.36K ≈ $361.11K |
-96.38% |
| 2005-06-30 | AU$14.11 Million ≈ $9.98 Million |
+391.68% |
| 2004-06-30 | AU$2.87 Million ≈ $2.03 Million |
+315.23% |
| 2003-06-30 | AU$690.97K ≈ $488.90K |
+109.68% |
| 2002-06-30 | AU$-7.14 Million ≈ $-5.05 Million |
-174.31% |
| 2000-06-30 | AU$9.61 Million ≈ $6.80 Million |
+30.21% |
| 1999-06-30 | AU$7.38 Million ≈ $5.22 Million |
-64.14% |
| 1998-06-30 | AU$20.58 Million ≈ $14.56 Million |
+47.79% |
| 1997-06-30 | AU$13.92 Million ≈ $9.85 Million |
+17.39% |
| 1996-06-30 | AU$11.86 Million ≈ $8.39 Million |
+136.03% |
| 1995-06-30 | AU$5.03 Million ≈ $3.56 Million |
-2.94% |
| 1994-06-30 | AU$5.18 Million ≈ $3.66 Million |
+1.57% |
| 1993-06-30 | AU$5.10 Million ≈ $3.61 Million |
-3.14% |
| 1992-06-30 | AU$5.26 Million ≈ $3.72 Million |
-3.41% |
| 1991-06-30 | AU$5.45 Million ≈ $3.85 Million |
-4.54% |
| 1990-06-30 | AU$5.71 Million ≈ $4.04 Million |
+15.81% |
| 1989-06-30 | AU$4.93 Million ≈ $3.49 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Resonance Health Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6723333800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$74.45 Million | 792.83% |
| Other Comprehensive Income | AU$2.54 Million | 27.08% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$9.39 Million | 100.00% |
Resonance Health Ltd Competitors by Market Cap
The table below lists competitors of Resonance Health Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The Navakij Insurance Public Company Limited
BK:NKI
|
$16.23 Million |
|
StarFlex Co. Ltd
KQ:115570
|
$16.23 Million |
|
Farmmi Inc
NASDAQ:FAMI
|
$16.23 Million |
|
123fahrschule SE
DU:123F
|
$16.23 Million |
|
E for L Aim Public Company Limited
BK:EFORL
|
$16.20 Million |
|
QMINES LTD
F:81V
|
$16.19 Million |
|
Observe Medical Asa
OL:OBSRV
|
$16.19 Million |
|
LEXINGTO GOLD NEW DL-003
F:XX40
|
$16.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Resonance Health Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,931,634 to 9,390,797, a change of -1,540,837 (-14.1%).
- Net loss of 1,732,939 reduced equity.
- Other comprehensive income decreased equity by 93,651.
- Other factors increased equity by 285,753.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.73 Million | -18.45% |
| Other Comprehensive Income | AU$-93.65K | -1.0% |
| Other Changes | AU$285.75K | +3.04% |
| Total Change | AU$- | -14.10% |
Book Value vs Market Value Analysis
This analysis compares Resonance Health Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.33x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.12x to 2.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-06-30 | AU$0.01 | AU$0.05 | x |
| 1990-06-30 | AU$0.01 | AU$0.05 | x |
| 1991-06-30 | AU$0.01 | AU$0.05 | x |
| 1992-06-30 | AU$0.02 | AU$0.05 | x |
| 1993-06-30 | AU$0.02 | AU$0.05 | x |
| 1994-06-30 | AU$0.02 | AU$0.05 | x |
| 1995-06-30 | AU$0.02 | AU$0.05 | x |
| 1996-06-30 | AU$0.06 | AU$0.05 | x |
| 1997-06-30 | AU$7.26 | AU$0.05 | x |
| 1998-06-30 | AU$6.58 | AU$0.05 | x |
| 1999-06-30 | AU$1.75 | AU$0.05 | x |
| 2000-06-30 | AU$1.67 | AU$0.05 | x |
| 2002-06-30 | AU$-1.45 | AU$0.05 | x |
| 2003-06-30 | AU$0.01 | AU$0.05 | x |
| 2004-06-30 | AU$0.06 | AU$0.05 | x |
| 2005-06-30 | AU$0.13 | AU$0.05 | x |
| 2006-06-30 | AU$0.00 | AU$0.05 | x |
| 2007-06-30 | AU$0.01 | AU$0.05 | x |
| 2008-06-30 | AU$0.01 | AU$0.05 | x |
| 2009-06-30 | AU$0.01 | AU$0.05 | x |
| 2010-06-30 | AU$0.01 | AU$0.05 | x |
| 2011-06-30 | AU$0.01 | AU$0.05 | x |
| 2012-06-30 | AU$0.01 | AU$0.05 | x |
| 2013-06-30 | AU$0.01 | AU$0.05 | x |
| 2014-06-30 | AU$0.01 | AU$0.05 | x |
| 2015-06-30 | AU$0.01 | AU$0.05 | x |
| 2016-06-30 | AU$0.01 | AU$0.05 | x |
| 2017-06-30 | AU$0.01 | AU$0.05 | x |
| 2018-06-30 | AU$0.01 | AU$0.05 | x |
| 2019-06-30 | AU$0.01 | AU$0.05 | x |
| 2020-06-30 | AU$0.02 | AU$0.05 | x |
| 2021-06-30 | AU$0.03 | AU$0.05 | x |
| 2022-06-30 | AU$0.02 | AU$0.05 | x |
| 2023-06-30 | AU$0.02 | AU$0.05 | x |
| 2024-06-30 | AU$0.02 | AU$0.05 | x |
| 2025-06-30 | AU$0.02 | AU$0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Resonance Health Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.65%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.91x
- Recent ROE (-18.45%) is above the historical average (-82.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -18.23% | 0.00% | 0.00x | 2.06x | AU$-3.93 Million |
| 1998 | 0.37% | 0.00% | 0.00x | 2.00x | AU$-1.78 Million |
| 1999 | 0.85% | 0.00% | 0.00x | 1.67x | AU$-492.17K |
| 2000 | 5.41% | 5.57% | 0.33x | 2.94x | AU$-358.82K |
| 2002 | 0.00% | -152.38% | 1.51x | 0.00x | AU$-1.75 Million |
| 2003 | 883.25% | 32119.36% | 0.03x | 1.04x | AU$6.03 Million |
| 2004 | 24.67% | 22941.94% | 0.00x | 1.02x | AU$450.22K |
| 2005 | 7.87% | 913.07% | 0.01x | 1.03x | AU$-300.68K |
| 2006 | -3147.02% | -5081.47% | 0.34x | 1.84x | AU$-16.11 Million |
| 2007 | -26.64% | -38.79% | 0.59x | 1.16x | AU$-997.11K |
| 2008 | -1.55% | -2.40% | 0.59x | 1.09x | AU$-308.90K |
| 2009 | 18.69% | 27.32% | 0.61x | 1.12x | AU$286.83K |
| 2010 | -3.18% | -5.55% | 0.49x | 1.16x | AU$-422.85K |
| 2011 | -10.95% | -18.16% | 0.50x | 1.20x | AU$-606.56K |
| 2012 | -10.48% | -17.22% | 0.47x | 1.31x | AU$-525.60K |
| 2013 | -9.10% | -13.36% | 0.50x | 1.37x | AU$-428.10K |
| 2014 | -2.17% | -3.17% | 0.53x | 1.28x | AU$-406.27K |
| 2015 | 10.52% | 18.96% | 0.47x | 1.18x | AU$22.71K |
| 2016 | -9.52% | -15.07% | 0.52x | 1.22x | AU$-787.39K |
| 2017 | -8.14% | -12.23% | 0.54x | 1.24x | AU$-677.47K |
| 2018 | 5.43% | 7.76% | 0.62x | 1.13x | AU$-188.80K |
| 2019 | 21.55% | 35.03% | 0.56x | 1.09x | AU$680.64K |
| 2020 | -7.22% | -19.49% | 0.35x | 1.06x | AU$-1.71 Million |
| 2021 | 4.95% | 15.50% | 0.30x | 1.05x | AU$-596.88K |
| 2022 | -10.68% | -29.83% | 0.33x | 1.09x | AU$-2.21 Million |
| 2023 | -7.85% | -17.71% | 0.40x | 1.11x | AU$-1.77 Million |
| 2024 | 1.55% | 1.97% | 0.42x | 1.86x | AU$-923.86K |
| 2025 | -18.45% | -15.65% | 0.62x | 1.91x | AU$-2.67 Million |
Industry Comparison
This section compares Resonance Health Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $8,552,489
- Average return on equity (ROE) among peers: -90.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Resonance Health Ltd (RHT) | AU$10.94 Million | -18.23% | 0.64x | $16.20 Million |
| Adheris Health Limited (AHE) | $2.78 Million | -35.73% | 0.18x | $136.67 |
| Alcidion Group Ltd (ALC) | $4.03 Million | -3.69% | 0.00x | $95.02 Million |
| ARTRYA Ltd (AYA) | $16.80 Million | -83.31% | 0.13x | $455.29 Million |
| Beamtree Holdings Ltd (BMT) | $47.14 Million | -10.83% | 0.27x | $24.68 Million |
| Cogstate Ltd (CGS) | $1.84 Million | -38.77% | 0.44x | $291.33 Million |
| Careteq Ltd (CTQ) | $1.52 Million | -4.75% | 2.91x | $2.06 Million |
| Doctor Care Anywhere Group Plc (DOC) | $15.82 Million | -127.77% | 0.24x | $41.51 Million |
| Echoiq Ltd (EIQ) | $22.76 Million | -58.28% | 0.03x | $468.78 Million |
| Emyria Ltd (EMD) | $499.54K | -537.08% | 6.06x | $28.53 Million |
| Enlitic Inc (ENL) | $-27.66 Million | 0.00% | 0.00x | $5.90 Million |
About Resonance Health Ltd
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron conce… Read more